Filing Details

Accession Number:
0001181431-11-036474
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-14 13:49:40
Reporting Period:
2011-06-10
Filing Date:
2011-06-14
Accepted Time:
2011-06-14 13:49:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389870 Omni Bio Pharmaceutical Inc. OMBP Biological Products, (No Disgnostic Substances) (2836) 208097969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1461584 C. Edward Larkin 5350 South Roslyn
Suite 430
Greenwood Village 80111
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-10 10,000 $0.00 510,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to Buy) Acquisiton 2011-06-10 10,000 $0.00 10,000 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2011-06-10 2016-06-10 No 4 P Direct
Footnotes
  1. The reporting person purchased 10,000 Units from the issuer in a private placement transaction for $1.25 per Unit. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.